tweenvest

Novo Nordisk A/S (CPSE: NOVO B)

Health Care · Pharmaceuticals · DK

Dkr265.15

-2.32% today · -11.0% 1Y

Public summary
A free snapshot of Novo Nordisk A/S, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Novo Nordisk A/S (CPSE: NOVO B) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $175.56B.

Over the last twelve months the share price has lost 11.0%, trading between 224.25 and 409.95.

Tweenvest scores Novo Nordisk A/S across four factors: quality 84/100, value 79/100, growth 63/100, dividend 96/100. Its strongest factor is dividend.

NOVO B price history

Nov 21, 2025 · 304.65Weekly closes 228.50 – 401.35Nov 18, 2026 · 271.45

Key figures

Market cap
$175.56B
Revenue (TTM)
$50.70B
P/E
10.65
EPS
25.47
Dividend yield
4.35%
Beta (5Y)
0.37
52-week high
Dkr409.95
52-week low
Dkr224.25
Avg volume (3M)
—
Shares outstanding
4.41B
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Roche Holding AGSWX: ROP$381.70BCHF399.20-1.04%
Merck & Co., Inc.NYSE: MRK$339.66B$132.12-4.11%
Novartis AGSWX: NOVN$294.48BCHF127.24-3.22%
AstraZeneca PLCLSE: AZN$278.14B£133.04-2.51%
Pfizer Inc.NYSE: PFE$159.94B$27.50-2.01%
Bristol-Myers Squibb CompanyNYSE: BMY$121.75B$58.12-2.42%
SanofiENXTPA: SAN$113.30B€83.79-2.85%
GSK plcLSE: GSK$97.88B£18.27-1.67%

Browse every Pharmaceuticals company →